Kayexalate and Weakness - a phase IV clinical study of FDA data
Weakness is found among people who take Kayexalate, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Kayexalate and have Weakness. It is created by eHealthMe based on reports of 4,576 people who have side effects when taking Kayexalate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,576 people reported to have side effects when taking Kayexalate.
Among them, 246 people (5.38%) have Weakness.
What is Kayexalate?
Kayexalate has active ingredients of sodium polystyrene sulfonate. eHealthMe is studying from 4,817 Kayexalate users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,323 drugs and 6,387 conditions by eHealthMe.
Number of Kayexalate and Weakness reports submitted per year:
Time on Kayexalate when people have Weakness *:
Gender of people who have Weakness when taking Kayexalate*:
Age of people who have Weakness when taking Kayexalate *:
Common drugs people take besides Kayexalate *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Kayexalate and have Weakness?Check whether Weakness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of sodium polystyrene sulfonate:
Alternative drugs to, pros and cons of Kayexalate:
- Kayexalate (4,817 reports)
Common Kayexalate side effects:
- Hyperkalemia (damage to or disease of the kidney): 503 reports
- Diarrhea: 280 reports
- Acute kidney failure: 278 reports
- Weakness: 246 reports
- Thrombocytopenia (decrease of platelets in blood): 238 reports
- Constipation: 232 reports
- Breathing difficulty: 226 reports
Browse all side effects of Kayexalate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Weakness treatments and more:
- Weakness (555,924 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
- Prednisone: 26,970 reports
- Aspirin: 26,881 reports
- Humira: 16,920 reports
- Methotrexate: 16,160 reports
- Metformin: 15,821 reports
- Omeprazole: 15,424 reports
- Tysabri: 14,800 reports
- Lisinopril: 14,469 reports
- Lipitor: 14,239 reports
- Synthroid: 13,523 reports
All the drugs that are associated with Weakness:
- Weakness (5,323 drugs)
Common conditions associated with Weakness:
- Multiple sclerosis: 44,054 reports
- High blood pressure: 24,528 reports
- Rheumatoid arthritis: 22,768 reports
- High blood cholesterol: 17,735 reports
- Pain: 15,197 reports
All the conditions that are associated with Weakness:
- Weakness (6,387 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sodium polystyrene sulfonate (the active ingredients of Kayexalate) and Kayexalate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Travatan and Peptic Ulcer Aggravated - 4 seconds ago
- Zoladex and Mitral Valve Prolapse - 7 seconds ago
- Zynlonta and Headache - 10 seconds ago
- Vancenase and Cheilitis - 11 seconds ago
- Xarelto and Blood Urea Increased - 14 seconds ago
- Fentanyl and Dilaudid drug interaction - 16 seconds ago
- Gilenya and Seborrhoeic Keratosis - 18 seconds ago
- Crestor and Cough - 18 seconds ago
- Starlix and Zetia drug interaction - 20 seconds ago
- Tamsulosin Hydrochloride and Depressed Level Of Consciousness - 20 seconds ago